Cannara Biotech (TSXV:LOVE) - Hisse Senedi Fiyatı, Haberler ve Analizler

LOVE Stoklara Genel Bakış

Cannara Biotech Inc. iştirakleri ile birlikte Kanada'da kapalı alanda kenevir ve kenevir türevi ürünlerin yetiştirilmesi, işlenmesi ve satışı ile uğraşmaktadır.

Şirket hakkında

LOVE temel anali̇z
Kar Tanesi Skoru
Değerleme	2/6
Gelecekteki Büyüme	0/6
Geçmiş Performans	1/6
Finansal Sağlık	3/6
Temettüler	0/6

Ödüller

Fiyat-Kazanç oranı ( 11.9 x) Canadian piyasasının ( 14.9 x) altındadır

Kazançlar son 5 yılda yılda 74.5% oranında arttı

Risk Analizi

Faiz ödemeleri kazançlarla iyi karşılanmıyor

Finansal sonuçları etkileyen büyük tek seferlik kalemler

Anlamlı bir piyasa değeri yok ( CA$63M )

Son 3 ayda dalgalı hisse senedi fiyatı

Cannara Biotech Inc. Rakipler

Jamieson Wellness

TSX:JWEL

CA$1.4b

Koios Beverage

CNSX:FIT

CA$473.6k

KP Tissue

TSX:KPT

CA$81.8m

4MASS Spólka Akcyjna

WSE:4MS

zł169.0m

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Cannara Biotech
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatı	CA$0.70
52 Haftanın En Yüksek Seviyesi	CA$1.04
52 Haftanın En Düşük Seviyesi	CA$0.52
Beta	1.08
11 Aylık Değişim	6.06%
3 Aylık Değişim	12.90%
1 Yıllık Değişim	-25.53%
33 Yıllık Değişim	-50.00%
5 Yıllık Değişim	-50.00%
Halka arzdan bu yana değişim	-77.05%

Son Haberler & Güncellemeler

These 4 Measures Indicate That Cannara Biotech (CVE:LOVE) Is Using Debt Extensively

Oct 29

Cannara Biotech Inc.'s (CVE:LOVE) 33% Price Boost Is Out Of Tune With Earnings

Aug 22

Cannara Biotech (CVE:LOVE) Shareholders Will Want The ROCE Trajectory To Continue

Aug 21

Does Cannara Biotech (CVE:LOVE) Have A Healthy Balance Sheet?

Jul 14

Recent updates

These 4 Measures Indicate That Cannara Biotech (CVE:LOVE) Is Using Debt Extensively

Oct 29

Cannara Biotech Inc.'s (CVE:LOVE) 33% Price Boost Is Out Of Tune With Earnings

Aug 22

Cannara Biotech (CVE:LOVE) Shareholders Will Want The ROCE Trajectory To Continue

Aug 21

Does Cannara Biotech (CVE:LOVE) Have A Healthy Balance Sheet?

Jul 14

Cannara Biotech Inc.'s (CVE:LOVE) Prospects Need A Boost To Lift Shares

May 09

Here's Why We Think Cannara Biotech (CVE:LOVE) Might Deserve Your Attention Today

Feb 28

Cannara Biotech Inc.'s (CVE:LOVE) Business Is Yet to Catch Up With Its Share Price

Apr 10

Here's Why Cannara Biotech (CVE:LOVE) Has A Meaningful Debt Burden

Jan 26

Cannara Biotech's (CVE:LOVE) Earnings Aren't As Good As They Appear

Jan 27

Cannara Biotech (CVE:LOVE) Has A Somewhat Strained Balance Sheet

Dec 10

Here's Why Cannara Biotech (CSE:LOVE) Can Afford Some Debt

Mar 16

Can You Imagine How Cannara Biotech's (CSE:LOVE) Shareholders Feel About The -6.5% Share Price Increase?

Jan 22

Have Insiders Been Buying Cannara Biotech Inc. (CSE:LOVE) Shares?

Dec 18

Hissedar Getirileri

	LOVE	CA Personal Products	CA Pazar
7D	4.5%	-3.0%	-1.1%
1Y	-25.5%	12.1%	20.8%

Getiri vs. Endüstri: LOVE geçen yıl % 12.1 oranında getiri sağlayan Canadian Personal Products sektörünün gerisinde kaldı.

Getiri vs Piyasa: LOVE geçen yıl % 20.8 oranında getiri sağlayan Canadian Piyasasının altında performans gösterdi.

Fiyat Oynaklığı

Is LOVE's price volatile compared to industry and market?
LOVE volatility
LOVE Average Weekly Movement	13.6%
Personal Products Industry Average Movement	8.5%
Market Average Movement	8.3%
10% most volatile stocks in CA Market	17.5%
10% least volatile stocks in CA Market	2.9%

İstikrarlı Hisse Senedi Fiyatı: LOVE hisse senedi fiyatı son 3 aydır dalgalı bir seyir izliyor.

Zaman İçindeki Volatilite: LOVE 'nin haftalık oynaklığı ( 14% ) geçen yıl boyunca sabit kaldı, ancak hala Canadian hisselerinin %75'inden yüksek.

Şirket Hakkında

Kuruldu	Çalışanlar	CEO	Web sitesi
2017	n/a	Zohar Krivorot	cannara.ca

Cannara Biotech Inc. iştirakleri ile birlikte Kanada'da kapalı alanda kenevir ve kenevir türevi ürünlerin yetiştirilmesi, işlenmesi ve satışı ile uğraşmaktadır. Ayrıca kenevir bazlı CBD ürünleri de sunmaktadır. Şirket, ürünlerini toptancılar ve çevrimiçi satıcılar aracılığıyla satmaktadır.

Cannara Biotech Inc. Temel Bilgiler Özeti

Cannara Biotech'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
LOVE temel i̇stati̇sti̇kler
Piyasa değeri	CA$63.01m
Kazançlar(TTM)	CA$5.32m
Gelir(TTM)	CA$76.69m

11.9x

F/K Oranı

0.8x

P/S Oranı

LOVE aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
LOVE gelir tablosu (TTM)
Gelir	CA$76.69m
Gelir Maliyeti	CA$47.81m
Brüt Kâr	CA$28.88m
Diğer Giderler	CA$23.56m
Kazançlar	CA$5.32m

Son Raporlanan Kazançlar

May 31, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)	0.059
Brüt Marj	37.65%
Net Kâr Marjı	6.93%
Borç/Özkaynak Oranı	58.9%

LOVE uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

LOVE Stoklara Genel Bakış

Ödüller

Risk Analizi

Cannara Biotech Inc. Rakipler

TSX:JWEL

CA$1.4b

CNSX:FIT

CA$473.6k

TSX:KPT

CA$81.8m

WSE:4MS

zł169.0m

Fiyat Geçmişi ve Performans

Son Haberler & Güncellemeler

These 4 Measures Indicate That Cannara Biotech (CVE:LOVE) Is Using Debt Extensively

New minor risk - Share price stability

Cannara Biotech Inc.'s (CVE:LOVE) 33% Price Boost Is Out Of Tune With Earnings

Cannara Biotech (CVE:LOVE) Shareholders Will Want The ROCE Trajectory To Continue

Third quarter 2024 earnings released: EPS: CA$0.022 (vs CA$0.033 in 3Q 2023)

Does Cannara Biotech (CVE:LOVE) Have A Healthy Balance Sheet?

Recent updates

These 4 Measures Indicate That Cannara Biotech (CVE:LOVE) Is Using Debt Extensively

New minor risk - Share price stability

Cannara Biotech Inc.'s (CVE:LOVE) 33% Price Boost Is Out Of Tune With Earnings

Cannara Biotech (CVE:LOVE) Shareholders Will Want The ROCE Trajectory To Continue

Third quarter 2024 earnings released: EPS: CA$0.022 (vs CA$0.033 in 3Q 2023)

Does Cannara Biotech (CVE:LOVE) Have A Healthy Balance Sheet?

Cannara Biotech Inc.'s (CVE:LOVE) Prospects Need A Boost To Lift Shares

Second quarter 2024 earnings released: CA$0.038 loss per share (vs CA$0.007 loss in 2Q 2023)

Here's Why We Think Cannara Biotech (CVE:LOVE) Might Deserve Your Attention Today

First quarter 2024 earnings released: EPS: CA$0.023 (vs CA$0 in 1Q 2023)

Investor Optimism Abounds Cannara Biotech Inc. (CVE:LOVE) But Growth Is Lacking

Cannara Biotech's (CVE:LOVE) Earnings May Just Be The Starting Point

Full year 2023 earnings released: EPS: CA$0.078 (vs CA$0.026 in FY 2022)

Insufficient new directors

Cannara Biotech Inc., Annual General Meeting, Jan 25, 2024

Is Cannara Biotech (CVE:LOVE) A Risky Investment?

Third quarter 2023 earnings released: EPS: CA$0.03 (vs CA$0.016 in 3Q 2022)

Independent Director recently bought CA$60k worth of stock

Investor sentiment improves as stock rises 24%

Second quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.013 loss in 2Q 2022)

Cannara Biotech Inc.'s (CVE:LOVE) Business Is Yet to Catch Up With Its Share Price

Here's Why Cannara Biotech (CVE:LOVE) Has A Meaningful Debt Burden

First quarter 2023 earnings released: EPS: CA$0 (vs CA$0.001 loss in 1Q 2022)

Cannara Biotech Inc., Annual General Meeting, Jan 25, 2023

Independent Director recently bought CA$117k worth of stock

Full year 2022 earnings released: EPS: CA$0.003 (vs CA$0.002 loss in FY 2021)

Cannara Biotech Inc. Announces Entry into the British Columbia Market and the Launch of Its First Vape Cartridge and Vape Accessory, Tribal G Mint and Uni Pro Ark

Independent Director recently bought CA$81k worth of stock

Third quarter 2022 earnings released: EPS: CA$0.002 (vs CA$0.002 in 3Q 2021)

Second quarter 2022 earnings released: CA$0.001 loss per share (vs CA$0.001 loss in 2Q 2021)

Cannara Biotech's (CVE:LOVE) Earnings Aren't As Good As They Appear

First quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Cannara Biotech Inc. Announces New Products Launch

Cannara Biotech (CVE:LOVE) Has A Somewhat Strained Balance Sheet

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

High number of new directors

Cannara Biotech Inc. Receives Processing and Cultivation License

Cannara Biotech Inc. Receives Amendment of Its Licence from Health Canada Permitting the Sale of Cannabis 2.0 Products and Prepares for the Launch of Its Hash Product Line in Quebec

Third quarter 2021 earnings released: EPS CA$0.002 (vs CA$0.003 loss in 3Q 2020)

Cannara Biotech Inc. (TSXV:LOVE) completed the acquisition of Quebec Facility of Medican Organic Inc.

Cannara Biotech Inc. (TSXV:LOVE) entered into an agreement to acquire Quebec Facility of Medican Organic Inc. for CAD 32.7 million.

Here's Why Cannara Biotech (CSE:LOVE) Can Afford Some Debt

First quarter 2021 earnings released: CA$0.005 loss per share (vs CA$0.004 loss in 1Q 2020)

Can You Imagine How Cannara Biotech's (CSE:LOVE) Shareholders Feel About The -6.5% Share Price Increase?

Have Insiders Been Buying Cannara Biotech Inc. (CSE:LOVE) Shares?

Full year 2020 earnings released: CA$0.017 loss per share

Cannara Biotech Inc., Annual General Meeting, Jan 25, 2021

Cannara Biotech Inc. Appoints Donald Olds to Board of Directors

Hissedar Getirileri

Fiyat Oynaklığı

Şirket Hakkında

Cannara Biotech Inc. Temel Bilgiler Özeti

11.9x

0.8x

Kazanç ve Gelir